蛋白酶激活受体 (PAR):在外科手术期间中风中的生物学和治疗潜力
Theodoros Mavridis1,2, Theodora Choratta3, Androniki Papadopoulou4
1Department of Neurology, Tallaght University Hospital (TUH)/The Adelaide and Meath Hospital, Dublin, incorporating the National Children's Hospital (AMNCH), Dublin, D24 NR0A, Ireland.
Translational stroke research
|February 7, 2024
概括
术后中风是一种严重的手术风险. 蛋白酶激活受体 (PAR) 在脑缺血中具有双重作用,为手术患者中风预防提供潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 心血管科学 心血管科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 术后中风是手术后的一种严重并发症,由于被镇静剂和麻醉剂掩盖,经常被低估.
- 了解外科手术前中风的病理生理学对于确定有效的治疗点至关重要.
- 蛋白酶激活受体 (PAR) 是关键的G蛋白合受体,参与许多生理和病理过程.
研究的目的:
- 审查PARs的生物学和重要性.
- 概述PAR在健康和疾病中的各种功能.
- 探索PARs在脑血管生理学,病理生理学和神经保护方面的参与,特别是关于中风.
主要方法:
- 对蛋白酶激活受体 (PAR) 的研究的文献综述.
- 分析PAR在生理和病理过程中的作用.
- 研究PARs在脑血管 (病理) 生理学和神经保护方面的参与.
主要成果:
- PARs被广泛表达,并在各种身体功能中发挥关键作用.
- PARs与大脑血管生理学和病理生理学密切相关.
- PARs在脑缺血中发挥了双重作用,表明了治疗潜力.
结论:
- 蛋白酶激活受体 (PAR) 在脑血管功能和功能障碍方面具有重要作用.
- PARs在脑缺血中的双重作用使它们成为潜在的治疗点.
- 准PAR可能有助于减轻手术患者中风的严重后果.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K